What is COVID-19?

COVID-19 is caused by the SARS-CoV-2 virus. Symptoms of COVID-19 may start to appear anywhere from 2-14 days after exposure to the virus. The mean incubation period is ~ 5 days but ranges from 2-14 days.

What tests are available?

We have 2 types of diagnostic testing available at Atracare:

Rapid antigen tests ( results ~15 minutes): detects the protein on the outer surface of the COVID-19 virus. They are very specific for the virus but not as sensitive as the molecular tests. This means that a positive result is highly accurate but a negative result does not rule out infection necessarily. The possibility of a false negative result should be considered in the context of a patient’s recent exposures and the presence of clinical signs and symptoms consistent with COVID-19.

RT-PCR molecular tests (results in several days): detects genetic material from the COVID-19 virus and is highly accurate.

COVID-19 IgG/IgM testing: CDC does not currently recommend using antibody testing for diagnosis of acute infection. In certain situations, serologic assays may be used to support clinical assessment of persons who present late in their illnesses when used in conjunction with viral detection tests. In addition, if a person is suspected to have a post-infectious syndrome caused by SARS-CoV-2 infection (e.g., Multisystem Inflammatory Syndrome in Children; MIS-C), serologic assays may be used.

What are the symptoms of COVID-19?

Patients can have symptoms and be infectious OR be asymptomatic and still infectious. Symptomatic persons may include those with fever ≥ 100.4°F, shaking chills, severe sore throat, loss of taste or smell, shortness of breath, cough, or muscle aches. Other symptoms including headache, nausea, vomiting, and diarrhea, and others have been identified as potential COVID-19 symptoms and may prompt further screening, action, or investigation. A patient with COVID-19 may be contagious 48-72 hours before starting to experience symptoms.

When to discontinue home isolation? (does not apply to healthcare workers)

The data we have to date shows that a person who has recovered from COVID-19 may still show low levels of the virus in their bodies for up to 3 months after their diagnosis. They may continue to have a positive result even though they may not be spreading the virus. There are NO confirmed reports of reinfection within the first 3 months of the initial infection but research is still ongoing. Thus, if a person who has recovered from COVID-19 has new symptoms, they may be re-infected.
If testing was positive: SYMPTOM based strategy NOT testing based strategy, per CDC recommendations as of September, 2020:

– at least 10 days from symptoms onset
at least 24 hours FEVER FREE with NO fever-reducing medications
-Improvement of symptoms
Delaware Department of Health recommends for patients to continue to self-monitor for symptoms for 14 days after they last had symptoms.

-10 days after the date of their first positive test if they remain symptom free

What qualifies as an exposure?

  • You were within 6 feet of someone with COVID-19 for 15 minutes or more over a 24 hour period (note: people can be infectious 2 days before they were sick, while they were sick or if they never developed symptoms, 2 days before they test positive and up to 10 days after exposure.)
  • You cared for someone with COVID-19
  • You hugged or kissed someone with COVID-19
  • You shared eating or drinking utensils with an infected person
  • You were coughed or sneezed on by an infected person

It is not an exposure if you were around someone who has had contact with someone else who was positive. Only confirmed cases count as a true exposure.

What do I do if I think I’ve been exposed?

At Atracare, we strictly follow the following CDC guidelines:

You need to quarantine at home and stay away from others. We highly recommend you get tested on day 5 or later AFTER your exposure. If you test earlier, the test is not useful and will waste valuable resources during this pandemic. If you do not want to get tested, you need to stay in quarantine until day 10 after your exposure. Monitor for symptoms of COVID-19 and if you develop any, you should be tested at that time for COVID-19.

What are the medication considerations?

FDA, European Medicines Agency (EMA) and the WHO do NOT recommend NSAIDS be avoided when clinically indicated.
NSAIDS have been theorized to cause harm in patients with COVID but clinical data is limited.

Inhaled glucocorticoids
Do NOT stop these medications for patients with asthma/COPD.
There is no good evidence that inhaled glucocorticoids increase susceptibility to COVID or have adverse effects on the course of infection.

Systemic glucocorticoids
If a COVID + AND with acute COPD/asthma exacerbation- you SHOULD give treatment with systemic steroids by usual guidelines.While the WHO and CDC recommend glucocorticoids not be routinely used in the treatment of COVID-19 infections, exacerbations with asthma and COPD are considered appropriate indications for use.

CDC ( 2020), UpToDate (2020)

Click here to schedule a COVID-19 test

12 New comments

Danny Ferguson | Reply

Can I schedule an appointment to receive a COVID-19 vaccine for me and my wife? We are both 71, living in Lewes DE.

    William Albanese | Reply

    Hi Danny! We have asked the state to provide us with enough vaccine to begin administering it to the public and hope to get some soon. When we do, we will launch a scheduler on our website and those that qualify can sign up. Stay tuned!

Karen Levin | Reply

Is there a way to be contacted when you get the Covid19 vaccine? Thank you.

    William Albanese | Reply

    Hi Karen,

    For patients of the practice that meet the current criteria (1A or 65+ years old), we are keeping a waiting list. Email your name, date of birth, and the best phone number for you to info@aspirahealth.net and we will add you. Our hope is to get more vaccine soon.

    Thanks for the question!

Barbara Graziosi | Reply

My husband and I are 77. I have asthma and he has high blood pressure. Can we get an appointment for the vaccine?

    William Albanese | Reply


    For patients of the practice that meet the current criteria (1A or 65+ years old), we are keeping a waiting list. Email your name, date of birth, and the best phone number for you to info@aspirahealth.net and we will add you. Our hope is to get more vaccine soon.

    Thanks for the question!

Nicole Davis | Reply

Hello. How long does it take to get the results back from the lab for the RT-PCR test?

    William Albanese | Reply

    PCR tests go out to LabCorp for analysis and typically take between 3-5 days for a response. Hope that helps!

Pat Pomposelli | Reply

I received my fist Pfizer vaccine on February 3 & trying to make an appointment for my second shot as close to February 24th. as possible. I had to cancel my Prolia shot because it was due on February 2nd. & since I need to wait an additional 14 days that will bring me at least 6weeks over due for the Prolia.

    William Albanese | Reply

    We don’t schedule in advance. We will email you 1-3 days before your next shot is due. Please see our website on the vaccine. It outlines all this information for you. Thanks for reaching out!

Jacquelyn Bernardi | Reply

My husband and I are scheduled June 1 in your Lewes office for a Covid test for travel. It’s the PCR molecular test. However, in order for this test to meet Aruba gov’t requirements it must be one of 8 test brands.
Please tell me what brand you administer.

    William Albanese | Reply

    Our PCR tests are run as RT-PCR. They are sent to LabCorp’s national lab for processing and meet the requirements for travel to Aruba. Hope that helps and you enjoy your trip!

Leave a Reply

Your email address will not be published. Required fields are marked *

Latest News and Clinic Information

We are your partner in health. Stay up to date with latest news and information.

Atracare Hot Topics July 2024

Welcome to Atracare Hot Topics. In this July edition, we cover crucial health advisories, tips for surviving the severe heat wave, our stance on Governor Carney and House Bill 350, and insights from the 2024 Burden of Chronic Disease Report released by the DPH.

Read More

Atracare Hot Topic: DPH Releases 2024 Burden of Chronic Disease Report

The Delaware Division of Public Health (DPH) released the 2024 Burden of Chronic Disease in Delaware report, detailing the prevalence and impact of chronic diseases like heart disease, stroke, and diabetes. Chronic diseases account for seven of the top ten causes of death in Delaware, affecting tens of thousands and costing billions annually. Key findings highlight racial inequities and the stable or increasing prevalence and mortality rates for various conditions. DPH is committed to addressing health inequities and improving chronic disease prevention and management. Atracare supports these efforts with affordable, premium healthcare services. For more information, visit the DPH website.

Read More

Atracare: We Stand By Governor Carney and House Bill 350

Atracare supports Governor John Carney’s signing of House Bill 350, aimed at controlling healthcare costs in Delaware.  The new law establishes the Diamond State Hospital Review Board to ensure hospitals align pricing with state benchmarks, promoting transparency and reducing costs. Atracare continues to offer accessible healthcare services to Southern Delaware residents and visitors, accepting all major insurances. Visit Atracare’s clinics in Lewes or Ocean View for premium, affordable care.

Read More